A new “magic mushroom” compound may deliver psychedelic brain benefits without the trip. Psilocybin, the psychoactive ingredient in “magic mushrooms,” is attracting increasing interest from scientists ...

Psilocybin - the psychoactive compound in "magic mushrooms" - is gaining scientific attention for its potential in treating ...

Experience Onward, Onaya Science, and Athletes Journey Home release new research using EEG technology A new pilot study from Experience Onward, one of the first licensed psilocybin treatment centers ...

A new study in mice suggests psychedelics make the brain more likely to "see" images from memory rather than what's actually ...

A new study published in Scientific Reports suggests that the therapeutic effects of psychedelic mushrooms likely rely on a complex interplay of multiple chemical compounds rather than just a single ...

Researchers develop 4e, a psilocin derivative that provides sustained serotonin activity without the hallucinogenic effects of magic mushrooms.

Psilocybin, a psychedelic compound contained in some varieties of mushrooms, has recently been found to be promising for the treatment of some neuropsychiatric disorders, including depression, some ...

While drug-induced mystical experiences can have benefits, research suggests they may not be enough to create lasting change.

Psilocybin—the psychoactive compound in "magic mushrooms"—is gaining scientific attention for its potential in treating ...

A new study in Communications Biology provides evidence that a psychedelic drug induces a hybrid sleep-wake state in active mice. This unusual brain activity suggests a potential mechanism for how ...

Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending side effects. Researchers created modified versions of psilocin — the active form of ...

New research reveals that psilocybin and MDMA promote long-term PTSD recovery by physically remodeling myelin insulation in ...